Novo Nordisk CEO agrees to appear at a Senate hearing to defend the ... had requested that Jørgensen not be the only industry representative in the GLP-1 agonist market to testify at the ...

Novo Nordisk's stock is still up more than 250% since Jørgensen took over as CEO in January 2017. But shares of Eli Lilly have gained about 800% since that same month, when CEO Dave Ricks took ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, ... Policy & Regulation category US energy firm EQT agrees to settle lawsuit for $167.5 million. June 27, 2025.

Ozempic maker Novo Nordisk NOVO.B-0.99%decrease; red down pointing triangle pushed out its chief executive after losing ground in the anti-obesity drug market, which has caused a steep stock-price ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down. The Danish company is citing a steep decline in the company’s share price.

Novo Nordisk, maker of weight loss drug Wegovy, ... Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down. Updated on: May 16, 2025 / 10:09 AM EDT / AP ...

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down, the Wegovy-maker said Friday, citing recent market challenges. The Danish pharmaceutical giant said Fruergaard Jørgensen would remain ...

Novo Nordisk's stock is still up more than 250% since Jørgensen took over as CEO in January 2017. But shares of Eli Lilly have gained about 800% since that same month, when CEO Dave Ricks took ...

“During his eight-year tenure as CEO, Novo Nordisk’s sales, profits and share price have almost tripled,” Novo Nordisk said. The 58-year-old Danish executive has spent his entire career at ...

Novo Nordisk's stock is still up more than 250% since Jørgensen took over as CEO in January 2017. But shares of Eli Lilly have gained about 800% since that same month, when CEO Dave Ricks took ...

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. Stream Los Angeles News for free, 24/7, wherever you are. The Danish drugmaker on ...